Sinotherapeutics Inc.

SHSE:688247 Stock Report

Market Cap: CN¥4.9b

Sinotherapeutics Balance Sheet Health

Financial Health criteria checks 6/6

Sinotherapeutics has a total shareholder equity of CN¥1.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.4B and CN¥192.4M respectively. Sinotherapeutics's EBIT is CN¥101.9M making its interest coverage ratio -6.9. It has cash and short-term investments of CN¥747.6M.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-6.9x
CashCN¥747.64m
EquityCN¥1.24b
Total liabilitiesCN¥192.42m
Total assetsCN¥1.43b

Recent financial health updates

No updates

Recent updates

Optimistic Investors Push Sinotherapeutics Inc. (SHSE:688247) Shares Up 27% But Growth Is Lacking

Nov 08
Optimistic Investors Push Sinotherapeutics Inc. (SHSE:688247) Shares Up 27% But Growth Is Lacking

Concerns Surrounding Sinotherapeutics' (SHSE:688247) Performance

Nov 02
Concerns Surrounding Sinotherapeutics' (SHSE:688247) Performance

Financial Position Analysis

Short Term Liabilities: 688247's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥112.4M).

Long Term Liabilities: 688247's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥80.0M).


Debt to Equity History and Analysis

Debt Level: 688247 is debt free.

Reducing Debt: 688247 had no debt 5 years ago.

Debt Coverage: 688247 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 688247 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies